Delivery Order SPE2DB22D3009-SPE2DB24FBC12

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,819.23, is for the supply of JANUVIA 100 MG TABLET 1000S, a prescription medication. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the delivery of JANUVIA 100 MG TABLET 90S, a prescription medication. The contract has a ceiling value of $1,030.06 and is a firm fixed-price delivery order. The ultimate completion date is September 12, 2024. The contract is not set-aside. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,842.21, is for the delivery of JANUVIA 100 MG TABLET 90S, a prescription medication. The contract is a firm fixed-price delivery order with a completion date of December 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUVIA 100 MG TABLET 1000S, a prescription medication, with a ceiling value of $11,708.63 and a performance period ending on February 7, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,341.96, is for the supply of JANUVIA 100 MG TABLET 90S, a drug used to treat type 2 diabetes. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through May 30, 2024. AmerisourceBergen has a larger $999,999,999 IDC with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JANUVIA 100 MG TABLET 90S. The contract has a ceiling value of $1,672.35 and a completion date of January 29, 2025. It is a firm fixed-price contract type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,031.10 and is for the delivery of JANUVIA 100 MG TABLET 1000S, a pharmaceutical product, with a completion date of January 2, 2025. The contract is a firm fixed-price arrangement and was not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,794.82 firm fixed-price contract is for the supply of JANUVIA 100 MG TABLET 90S, a pharmaceutical product, with a period of performance through February 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of JANUVIA 100 MG TABLET 90S, a prescription drug, with a ceiling value of $6,385.17 and a period of performance through July 9, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,502.24, is for the delivery of JANUVIA 100 MG TABLET 90S, a pharmaceutical product used in the treatment of diabetes. The contract is a firm fixed-price delivery order with a completion date of January 17, 2025. The contract has no set-aside designation, indicating open competition....
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB24FBC12
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, in the amount of $19,080.17. The contract is for the supply of JANUVIA 100 MG TABLET 90S, a prescription medication, with a performance period through August 6, 2024. The contract has a firm fixed price pricing type and is not a set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of pharmaceutical and medical products in support of military treatment facilities, veterans' healthcare, and other government healthcare programs nationwide.

Generated 11/4/24, 10:53 AM